Upregulating substance P levels to treat obstructive sleep apnea

Expert Opinion on Therapeutic Targets
Ahmet Ursavas

Abstract

The neuropeptide (tachykinin) substance P is widely distributed in the central and peripheral nervous systems. Substance P has been suggested to function as a neurotransmitter, cotransmitter, or neuromodulator in the central and peripheral nervous system. substance P also influences sleep physiology. Neurokinin 1 (NK-1) receptors may also be implicated in the control of sleep/wake behavior. Obstructive sleep apnea syndrome (OSAS) is defined as repeated episodes of upper airway occlusion during sleep with subsequent excessive daytime sleepiness (EDS). Substance P levels are found to be significantly lowered in patients with OSAS. The aim of this review was to investigate the relationship between substance P, EDS and other OSAS complications. The literature was searched using standard methods. Medline and Embase were searched systematically from 1974 to the end of February 2008 for relevant articles published in English. EDS seen in some OSAS patients may be associated with various pathophysiological mechanisms including changes in substance P levels. Intravenous substance P administration in OSAS patients can be effective in the treatment of EDS. Further studies on the possible relationship between low serum substance P and hype...Continue Reading

References

Jan 1, 1991·Annals of the New York Academy of Sciences·B V SastryL K Owens
Feb 1, 1989·The Journal of Clinical Endocrinology and Metabolism·R R GrunsteinC E Sullivan
Jul 1, 1988·Chest·C GuilleminaultG Nino-Murcia
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H KotaniS Nakanishi
Sep 1, 1994·Behavioral and Neural Biology·R U HasenöhrlJ P Huston
Sep 1, 1995·General Pharmacology·C A Maggi
Apr 1, 1993·Physiological Reviews·M Otsuka, K Yoshioka
Jan 1, 1997·The Journal of Clinical Investigation·D BrooksE A Phillipson
Nov 14, 1997·Trends in Pharmacological Sciences·C A Maggi, T W Schwartz
Jan 28, 1998·American Journal of Respiratory and Critical Care Medicine·C J WorsnopR J Pierce
Feb 2, 1999·American Journal of Respiratory and Critical Care Medicine·H M EnglemanN J Douglas
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·L SantarelliM J Heath
Mar 20, 2001·American Journal of Respiratory and Critical Care Medicine·E O BixlerA Kales
May 31, 2002·Pharmacological Reviews·Cinzia SeveriniVittorio Erspamer
Dec 5, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Klaus LiebUlrich Voderholzer
Apr 17, 2003·British Medical Bulletin·Rebecca Elliott
Dec 11, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark S KramerYih Lee
Jan 16, 2004·Trends in Pharmacological Sciences·Riccardo PatacchiniCarlo Alberto Maggi
Jan 20, 2004·Life Sciences·Jocelyn N PennefatherCarlo Alberto Maggi
Jun 24, 2004·European Journal of Pharmacology·Francisco M PintoM Luz Candenas
Jul 29, 2004·Current Medicinal Chemistry·T A AlmeidaM L Candenas
Nov 6, 2004·Brain Research·Gongliang ZhangJingxing Zhang
Jan 29, 2005·Journal of Applied Physiology·Robert J ThomasKenneth K Kwong
Sep 21, 2005·Sleep·Vishesh K KapurF Javier Nieto
Oct 15, 2005·Behavioural Brain Research·Monica L AndersenSergio Tufik
Feb 4, 2006·The European Respiratory Journal·G V RobinsonJ R Stradling

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical and Experimental Pharmacology & Physiology
E Burcher
Respiration; International Review of Thoracic Diseases
M BodelssonK Törnebrandt
Pathologie-biologie
V Staniek, L Misery
© 2022 Meta ULC. All rights reserved